Thus, KSHV latent infection must induce and maintain the induction of intrinsic apoptosis in the infected endothelial cell and require the cellular anti-apoptotic protein, Bcl-xL, to prevent cell death throughout the course of latency. This evidence concerns the gene BCL2L1 and disease arising from reactivation of latent virus.